Anatomy & Physiology Study Guide
21

The Endocrine System

Chapter 21Regulation, Integration, and Control9 h6 sections, outcomes 1-35Week 16

Slide deck, 35 slidesFlashcards, 96Practice questions, 57 in the bank

21.1

Hormone Classes, Synthesis, Transport, and Mechanisms of Action

1.5 hMonday, Mar 1, Week 16

Outcomes

  1. 1Classify hormones as peptide/protein, steroid, amine (catecholamine or thyroid) or eicosanoid and predict storage, transport and half-life from the class.
  2. 2Compare the signalling cascades of Gs, Gi, Gq, receptor tyrosine kinase, cytokine (JAK-STAT) and guanylyl cyclase receptors with a named hormone for each.
  3. 3Explain how nuclear receptors for steroid, thyroid, vitamin D and retinoid hormones alter gene transcription and why the onset is slower than for membrane receptors.
  4. 4Describe how binding proteins, clearance and metabolism set free-hormone concentration and plasma half-life.
  5. 5Distinguish negative feedback, positive feedback, long/short/ultrashort loops and pulsatile versus circadian secretion with one example each.
  6. 6Explain receptor up- and down-regulation, desensitization and permissive, synergistic and antagonistic hormone interactions.

Outline

  1. A

    Chemical classes and synthesis

    1. Peptides/proteins are made as preprohormones, cleaved in ER and Golgi, stored in secretory granules and released by Ca2+-triggered exocytosis; circulate free; half-life minutes.
    2. Steroids derive from cholesterol, are not stored (made on demand), are lipophilic, travel bound to carrier proteins; half-life hours.
    3. Amines come from tyrosine (catecholamines, thyroid hormones) or tryptophan (melatonin); catecholamines are stored in granules and are hydrophilic, thyroid hormones are lipophilic and heavily protein bound.
    4. Eicosanoids (prostaglandins, leukotrienes, thromboxane) are made from membrane arachidonic acid and act locally (paracrine/autocrine).
    5. Endocrine, paracrine, autocrine, juxtacrine and neuroendocrine signalling differ by distance travelled and carrier.
  2. B

    Membrane receptor signalling

    1. Gs receptors raise adenylyl cyclase, cAMP and protein kinase A (ACTH, glucagon, TSH, LH, FSH, PTH, beta-adrenergic); Gi lowers cAMP (somatostatin, alpha-2).
    2. Gq receptors activate phospholipase C, producing IP3 (Ca2+ release from ER) and DAG (protein kinase C): TRH, GnRH, oxytocin, alpha-1, V1.
    3. Receptor tyrosine kinases (insulin, IGF-1) autophosphorylate and recruit IRS proteins to PI3K-Akt and Ras-MAPK pathways.
    4. Cytokine-type receptors (GH, prolactin, leptin, EPO) have no intrinsic kinase and recruit JAK2, which phosphorylates STAT dimers that move to the nucleus.
    5. Guanylyl cyclase receptors raise cGMP (ANP/BNP); nitric oxide acts on soluble guanylyl cyclase.
    6. Signal amplification occurs at each step: one hormone molecule yields many second messengers; termination by phosphodiesterase and phosphatases.
  3. C

    Intracellular (nuclear) receptors

    1. Class I receptors (glucocorticoid, mineralocorticoid, androgen, estrogen, progesterone) sit in the cytoplasm with heat-shock proteins until ligand binding, then dimerize and enter the nucleus.
    2. Class II receptors (thyroid hormone, vitamin D, retinoic acid) are already nuclear, heterodimerize with RXR and bind response elements.
    3. Receptor-ligand complex binds hormone response elements (HREs) and recruits co-activators or co-repressors, changing transcription; effect takes hours.
  4. D

    Transport, clearance and measurement

    1. Binding proteins: cortisol-binding globulin (CBG, about 90 percent bound) spot-check, SHBG for sex steroids, thyroxine-binding globulin (TBG); only free hormone is active.
    2. Estrogen raises CBG and TBG, so total hormone rises while free hormone is unchanged.
    3. Clearance routes: receptor-mediated internalization, enzymatic degradation, hepatic conjugation, renal excretion.
    4. Immunoassays (RIA, ELISA) measure concentration; always interpret against the matching feedback hormone.
  5. E

    Control of secretion and receptor regulation

    1. Negative feedback is the rule (cortisol suppresses CRH/ACTH); positive feedback is rare (estrogen-driven LH surge, oxytocin in labor).
    2. Long, short and ultrashort feedback loops refer to target-hormone, pituitary-hormone and local effects on the hypothalamus or releasing cell.
    3. Secretion patterns: pulsatile (GnRH, GH), circadian (cortisol peak near waking), and stimulus-driven (insulin after glucose).
    4. Down-regulation follows sustained high ligand (insulin receptors in obesity); continuous GnRH desensitizes gonadotrophs, which is the basis of GnRH agonist therapy.
    5. Permissive (cortisol permits catecholamine effects), synergistic (GH plus cortisol raise glucose) and antagonistic (insulin versus glucagon) interactions.

Lab

  • Draw from memory the Gs/cAMP, Gq/IP3-DAG, tyrosine kinase and JAK-STAT cascades side by side, labelling receptor, transducer, effector, second messenger and end effect.
  • Label the endocrine glands and their positions on NET plate BP10 with labels covered.
  • Sort a list of 20 hormones into class, receptor type and transport form.
21.2

Hypothalamic-Pituitary Axis

1.5 hTuesday, Mar 2, Week 16

Outcomes

  1. 7Describe the embryologic origin, parts and blood supply of the pituitary, including the hypophyseal portal system.
  2. 8Name each hypothalamic releasing and inhibiting hormone with its anterior pituitary target cell and product.
  3. 9Explain growth hormone secretion, IGF-1 mediation and metabolic actions, and predict acromegaly and pituitary dwarfism.
  4. 10Explain the synthesis, transport and release of ADH and oxytocin from the posterior pituitary and the stimuli that control each.
  5. 11Interpret stimulation and suppression test logic for pituitary axes, including a dexamethasone suppression and an oral glucose GH suppression.
  6. 12Identify acidophils, basophils, chromophobes, Herring bodies and pituicytes on pituitary slides.

Outline

  1. A

    Anatomy and vasculature

    1. Adenohypophysis arises from Rathke pouch (oral ectoderm); neurohypophysis from a neuroectodermal downgrowth of the diencephalon.
    2. Parts: pars distalis, pars tuberalis, pars intermedia (adenohypophysis); pars nervosa, infundibulum, median eminence (neurohypophysis).
    3. Superior hypophyseal arteries form the primary capillary plexus in the median eminence; portal veins carry releasing hormones to the secondary plexus in the pars distalis.
    4. Inferior hypophyseal arteries supply the pars nervosa; sits in the sella turcica, below the optic chiasm, flanked by the cavernous sinuses.
    5. Mass effect gives bitemporal hemianopsia and may compress cavernous sinus nerves.
  2. B

    Hypothalamic control of the anterior pituitary

    1. TRH to thyrotrophs (TSH, also prolactin); CRH to corticotrophs (POMC to ACTH); GnRH to gonadotrophs (LH, FSH); GHRH to somatotrophs (GH); dopamine inhibits prolactin; somatostatin inhibits GH and TSH.
    2. Parvocellular neurons release into the portal system; GnRH must be pulsatile (about hourly) for gonadotroph function.
    3. POMC is cleaved to ACTH, beta-lipotropin and MSH peptides; excess ACTH causes skin darkening.
    4. Prolactin is the only anterior pituitary hormone under predominant tonic inhibition; stalk lesions raise prolactin and lower the others.
  3. C

    Growth hormone

    1. GH acts on the liver and other tissues through JAK2-STAT5 to make IGF-1; IGF-1 feeds back and stimulates somatostatin.
    2. Metabolic effects: lipolysis, reduced glucose uptake (anti-insulin), protein anabolism, chondrocyte growth at the epiphyseal plates.
    3. Secretion is pulsatile with peaks in deep sleep; stimulated by hypoglycemia, exercise, ghrelin, stress; inhibited by hyperglycemia and IGF-1.
    4. Excess before plate closure gives gigantism; after closure gives acromegaly (acral growth, prognathism, glucose intolerance, headache).
    5. Deficiency in children gives short stature with proportionate body; Laron dwarfism is GH-receptor resistance with high GH and low IGF-1.
  4. D

    Prolactin and the other tropic hormones

    1. Prolactin drives lactogenesis; its rise suppresses GnRH, causing amenorrhea and galactorrhea in prolactinoma.
    2. TSH, ACTH, FSH and LH act through Gs receptors; ACTH also trophic for the adrenal cortex.
    3. Panhypopituitarism order of loss commonly GH and gonadotropins first, then TSH, then ACTH.
  5. E

    Posterior pituitary

    1. ADH (vasopressin) and oxytocin are nonapeptides made in supraoptic and paraventricular nuclei, carried with neurophysin along the hypothalamo-hypophyseal tract and released from axon terminals.
    2. ADH release is driven by plasma osmolality (set point near 285 mOsm/kg spot-check) and by hypovolemia or hypotension; V2 receptors insert aquaporin-2 in collecting-duct principal cells, V1 constricts vessels.
    3. Central diabetes insipidus (low ADH) and nephrogenic diabetes insipidus (V2 or AQP2 defect) both give dilute polyuria; response to desmopressin separates them.
    4. SIADH gives euvolemic hyponatremia with inappropriately concentrated urine.
    5. Oxytocin acts through Gq to contract uterine myometrium (positive feedback in labor, Ferguson reflex) and myoepithelial cells in milk let-down.
  6. F

    Test logic for pituitary axes

    1. Interpret target-gland hormone together with the pituitary tropic hormone: low T4 with high TSH is primary, low T4 with low TSH is central.
    2. Stimulation tests confirm deficiency (insulin tolerance or glucagon stimulation for GH and ACTH, cosyntropin test for adrenal reserve); suppression tests confirm autonomy (oral glucose fails to suppress GH in acromegaly).
    3. Low-dose dexamethasone should suppress ACTH and cortisol; failure supports Cushing syndrome, and high-dose dexamethasone suppresses pituitary but not ectopic sources.

Lab

  • Label hypothalamic nuclei, infundibulum, portal vessels, adenohypophysis and neurohypophysis on NET plates 158 and BP30 with labels covered.
  • Histology Guide MH-149 and MH-150a: separate pars distalis from pars nervosa, then classify acidophils, basophils and chromophobes; find Herring bodies.
  • R&P plates 76-77: identify pars intermedia colloid cysts and pars tuberalis.
  • Diagram the hypothalamic-pituitary-target axis for ACTH, TSH and GH with stimulation (+) and suppression (-) signs, then add a clinical test to each.
21.3

Thyroid Gland

1.5 hWednesday, Mar 3, Week 16

Outcomes

  1. 13Describe the gross relations, blood supply and embryologic origin of the thyroid, including the thyroglossal duct tract.
  2. 14Identify follicles, colloid, follicular cells and parafollicular C cells on a thyroid slide and relate follicle height to activity.
  3. 15Sequence the steps of thyroid hormone synthesis from iodide trapping to secretion and name the enzyme and drug blocking each step.
  4. 16Explain peripheral T4-to-T3 conversion, transport proteins and the mechanism and metabolic effects of thyroid hormone.
  5. 17Predict laboratory patterns (TSH, free T4) in primary and central hypo- and hyperthyroidism and in Graves and Hashimoto disease.

Outline

  1. A

    Gross anatomy and development

    1. Two lobes joined by an isthmus over tracheal rings 2-3, anterior to the trachea; lies deep to sternothyroid and sternohyoid muscles.
    2. Arterial supply: superior thyroid artery (external carotid) and inferior thyroid artery (thyrocervical trunk); thyroid ima artery is a variant.
    3. Recurrent laryngeal nerve runs near the inferior thyroid artery and external branch of the superior laryngeal nerve near the superior artery: both at risk in thyroidectomy.
    4. Develops from the foramen cecum, descends as the thyroglossal duct; persistence gives thyroglossal cyst, and pyramidal lobe is a remnant.
  2. B

    Histology

    1. Follicles lined by simple cuboidal epithelium surround colloid rich in thyroglobulin; active glands show columnar cells and scalloped colloid, resting glands flat cells and abundant colloid.
    2. Parafollicular C cells are pale, sit between follicles or in the basal portion of the epithelium and make calcitonin.
    3. Fenestrated capillaries surround follicles, allowing hormone entry.
  3. C

    Hormone synthesis

    1. Na+/I- symporter (NIS) concentrates iodide against a gradient; blocked by perchlorate or thiocyanate.
    2. Pendrin moves iodide to the apical lumen; thyroid peroxidase (TPO) oxidizes iodide and iodinates tyrosine residues of thyroglobulin, forming MIT and DIT.
    3. TPO couples MIT and DIT into T3 (MIT+DIT) and T4 (DIT+DIT); thionamides (methimazole, PTU) inhibit TPO.
    4. TSH-driven endocytosis of colloid, lysosomal proteolysis and release of T4 and T3 into blood; excess iodide transiently blocks release (Wolff-Chaikoff effect).
    5. Output is about 90 percent T4 and 10 percent T3 spot-check; DIT is deiodinated within the cell to recycle iodide.
  4. D

    Transport, activation and actions

    1. Over 99 percent bound to TBG, transthyretin and albumin; free hormone only is active spot-check.
    2. Deiodinase type 1 and 2 convert T4 to T3 (active); type 3 makes reverse T3 (inactive); selenium dependent.
    3. T3 binds nuclear TR-RXR dimers and increases Na+/K+-ATPase, BMR and heat production, beta-adrenergic receptor expression, cardiac output.
    4. Permissive for growth and CNS development: untreated congenital hypothyroidism causes cretinism.
    5. Increases glycolysis, gluconeogenesis, lipolysis and cholesterol clearance via LDL receptors; hypothyroidism raises LDL.
  5. E

    Regulation and disease

    1. TRH raises TSH, TSH raises thyroid growth and hormone output; free T3/T4 inhibit TRH and TSH; TSH is the most sensitive test of primary disease.
    2. Graves disease: stimulating TSH-receptor antibodies cause diffuse goiter, exophthalmos, pretibial myxedema, low TSH.
    3. Hashimoto thyroiditis: anti-TPO and antithyroglobulin antibodies, lymphocytic infiltrate, hypothyroidism with high TSH.
    4. Dietary iodine deficiency causes goiter through persistently high TSH; recommended daily iodine intake about 150 micrograms spot-check.
    5. Thyroid storm and myxedema coma are the life-threatening extremes.

Lab

  • Label lobes, isthmus, pyramidal lobe, superior and inferior thyroid arteries and the recurrent laryngeal nerve on NET plates 87-88 with labels covered.
  • Histology Guide MH-151: find follicles, colloid, resorption lacunae and parafollicular cells; compare an active and a resting field.
  • R&P plate 79: distinguish thyroid from parathyroid tissue.
  • Draw the follicular cell with all synthesis steps (NIS, pendrin, TPO, endocytosis, deiodinase) and mark drug targets.
  • Fill in a TSH / free T4 / antibody table for six thyroid diagnoses.
21.4

Parathyroid Glands, Vitamin D, and Calcium-Phosphate Regulation

1 hWednesday, Mar 3, Week 16

Outcomes

  1. 18Locate the four parathyroid glands and their blood supply and identify chief and oxyphil cells on a slide.
  2. 19Explain the regulation of PTH secretion by extracellular Ca2+ through the calcium-sensing receptor.
  3. 20Describe PTH actions on bone, kidney and, indirectly, intestine.
  4. 21Trace vitamin D from skin or diet through hepatic 25-hydroxylation and renal 1-alpha-hydroxylation to calcitriol and describe its actions.
  5. 22Integrate PTH, calcitriol, calcitonin and FGF23 into a response to hypo- and hypercalcemia and interpret primary and secondary hyperparathyroidism.

Outline

  1. A

    Parathyroid gross and histologic anatomy

    1. Usually four glands posterior to the thyroid lobes; superior pair from pharyngeal pouch IV, inferior pair from pouch III (with thymus), explaining ectopic inferior glands in the mediastinum.
    2. Blood supply mainly from the inferior thyroid artery; at risk during thyroidectomy.
    3. Chief cells (dark, small, secrete PTH) and oxyphil cells (large, eosinophilic, mitochondria rich, appear after puberty) with increasing fat in adults.
  2. B

    PTH regulation and actions

    1. Calcium-sensing receptor (CaSR, Gq) on chief cells: low Ca2+ raises PTH within minutes; high Ca2+ suppresses it; low Mg2+ also impairs release.
    2. Bone: stimulates osteoblasts to express RANKL, activating osteoclasts and releasing Ca2+ and phosphate (high PTH continuous is catabolic, intermittent is anabolic).
    3. Kidney: increases Ca2+ reabsorption in the distal tubule, decreases phosphate reabsorption in the proximal tubule (phosphaturia) and activates 1-alpha-hydroxylase.
    4. Net effect: raises serum Ca2+ and lowers serum phosphate; acts through Gs-cAMP.
  3. C

    Vitamin D

    1. 7-Dehydrocholesterol in skin to cholecalciferol (D3) by UVB; plus dietary D2/D3.
    2. Liver 25-hydroxylation gives calcidiol (storage form, measured clinically); kidney 1-alpha-hydroxylase gives calcitriol (active), stimulated by PTH, low phosphate and low Ca2+.
    3. Calcitriol increases intestinal Ca2+ and phosphate absorption (calbindin, TRPV6), supports bone mineralization and feeds back to suppress PTH.
    4. Deficiency gives rickets in children and osteomalacia in adults.
  4. D

    Calcitonin, FGF23 and integration

    1. Calcitonin from C cells inhibits osteoclasts and lowers Ca2+ acutely but has minor physiologic role in adults; used pharmacologically and as a medullary thyroid carcinoma marker.
    2. FGF23 from osteocytes increases phosphate excretion and suppresses 1-alpha-hydroxylase.
    3. Ca2+ in plasma is roughly 45 percent protein bound, about 50 percent ionized, and total normal 8.5-10.5 mg/dL spot-check; albumin and pH change the ionized fraction.
    4. Hypocalcemia gives tetany, Chvostek and Trousseau signs; hypercalcemia gives stones, bones, groans and psychic moans.
    5. Primary hyperparathyroidism (adenoma): high Ca2+, low phosphate, high PTH; secondary (renal failure): low Ca2+, high phosphate, high PTH.

Lab

  • Label superior and inferior parathyroids relative to the thyroid and inferior thyroid artery on NET plate 89.
  • Histology Guide MH-154: identify chief and oxyphil cells, adipocytes and the capsule that separates parathyroid from thyroid.
  • Draw a flow diagram with PTH, calcitriol and calcitonin acting on bone, kidney and gut after a fall in plasma Ca2+.
  • Compare serum Ca2+, phosphate, PTH and 25-OH-D in four cases (primary, secondary, vitamin D deficiency, hypoparathyroidism).
21.5

Adrenal Cortex and Medulla; the Stress Response

2 hThursday, Mar 4, Week 16

Outcomes

  1. 23Identify the three cortical zones and the medulla on an adrenal slide and give the principal hormone of each.
  2. 24Outline steroidogenesis from cholesterol to aldosterone, cortisol and androgens, naming zone-specific enzymes at overview level.
  3. 25Explain regulation of aldosterone by the renin-angiotensin system and potassium, and its effects on the collecting duct.
  4. 26Explain the HPA axis, circadian rhythm and the metabolic, anti-inflammatory and permissive actions of cortisol.
  5. 27Describe catecholamine synthesis, adrenal medullary release and receptor-specific effects of epinephrine.
  6. 28Relate Cushing syndrome, Addison disease, congenital adrenal hyperplasia, Conn syndrome and pheochromocytoma to the pathways they disturb.
  7. 29Sequence the alarm, resistance and exhaustion phases of the stress response.

Outline

  1. A

    Anatomy and histology

    1. Retroperitoneal, superomedial to each kidney; right gland is pyramidal and posterior to the IVC, left is crescentic and posterior to the stomach and pancreas.
    2. Arterial supply: superior, middle and inferior suprarenal arteries; each gland drains by one vein (right into IVC, left into left renal vein); sympathetic preganglionic fibers directly innervate the medulla.
    3. Cortex zones from outside in: zona glomerulosa (rounded clusters, aldosterone), zona fasciculata (long cords of lipid-rich cells, cortisol), zona reticularis (anastomosing cords, DHEA/androgens); medulla of chromaffin cells.
    4. Mnemonic: salt (glomerulosa), sugar (fasciculata), sex (reticularis); medulla secretes epinephrine mainly.
  2. B

    Steroidogenesis

    1. Rate-limiting step: StAR moves cholesterol into mitochondria, cleaved to pregnenolone by CYP11A1 (desmolase).
    2. Glomerulosa lacks 17-alpha-hydroxylase and expresses aldosterone synthase (CYP11B2); fasciculata expresses 17-alpha-hydroxylase, 21-hydroxylase and 11-beta-hydroxylase to make cortisol.
    3. Reticularis makes DHEA and androstenedione via 17,20-lyase; peripheral conversion gives testosterone and estrogens.
    4. 21-Hydroxylase deficiency (commonest congenital adrenal hyperplasia): low cortisol, high ACTH, high 17-OH-progesterone, virilization, salt wasting in severe form.
    5. 11-Beta-HSD2 in kidney inactivates cortisol, protecting the mineralocorticoid receptor; licorice inhibits it.
  3. C

    Mineralocorticoids

    1. Aldosterone release is stimulated by angiotensin II (AT1, Gq), hyperkalemia and, weakly, ACTH; atrial natriuretic peptide inhibits.
    2. Acts on principal cells of the late distal tubule and collecting duct: increases ENaC and Na+/K+-ATPase, increases K+ secretion; intercalated cells secrete H+.
    3. Excess (Conn syndrome): hypertension, hypokalemia, metabolic alkalosis, low renin; deficiency: hypotension, hyponatremia, hyperkalemia.
  4. D

    Glucocorticoids and the HPA axis

    1. CRH to ACTH to cortisol; cortisol inhibits CRH and ACTH; secretion peaks near waking and is lowest at night.
    2. Metabolic actions: gluconeogenesis, protein catabolism, lipolysis with central fat redistribution, insulin resistance.
    3. Anti-inflammatory: inhibits phospholipase A2 (via lipocortin), reduces cytokine production, lymphocyte and eosinophil counts; raises neutrophils.
    4. Permissive for catecholamine vascular tone; fetal cortisol promotes surfactant and organ maturation.
    5. Cushing syndrome: central obesity, moon face, striae, proximal weakness, hypertension, hyperglycemia, osteoporosis; Cushing disease means a pituitary ACTH source; iatrogenic steroid use is the commonest cause.
    6. Addison disease: autoimmune adrenal destruction with hyperpigmentation (high ACTH/POMC), hypotension, hyponatremia, hyperkalemia; secondary insufficiency lacks hyperkalemia and pigmentation.
  5. E

    Adrenal medulla and catecholamines

    1. Tyrosine to L-DOPA (tyrosine hydroxylase, rate-limiting) to dopamine to norepinephrine to epinephrine by PNMT, which is induced by cortisol from the cortical portal flow.
    2. Preganglionic sympathetic ACh acting at nicotinic receptors triggers release; about 80 percent epinephrine spot-check.
    3. Alpha-1 vasoconstricts, beta-1 increases heart rate and contractility, beta-2 relaxes bronchi and vessels of muscle, increases glycogenolysis and lipolysis.
    4. Metabolized by MAO and COMT to metanephrines and VMA; pheochromocytoma gives episodic hypertension, headache, sweating, palpitations, diagnosed by plasma or urinary metanephrines.
  6. F

    Stress response

    1. Alarm (fight-or-flight): sympathetic and medullary catecholamines raise heart rate, glucose and blood flow to muscle.
    2. Resistance: sustained cortisol, GH, glucagon, ADH and aldosterone maintain glucose and fluid volume.
    3. Exhaustion: depleted reserves with prolonged cortisol exposure give immunosuppression, hypertension, hyperglycemia and mood disturbance.

Lab

  • Label adrenal gland, vessels and relations to kidney, IVC and diaphragm on NET plates 322-323 with labels covered.
  • Histology Guide MH-155a: delineate capsule, glomerulosa, fasciculata, reticularis and medulla; note sinusoids and medullary central vein.
  • R&P plates 80-81: identify chromaffin cells and cortical lipid vacuoles.
  • Draw the steroidogenic tree with enzymes, zones and the consequences of 21-hydroxylase, 11-beta-hydroxylase and 17-alpha-hydroxylase deficiency.
  • Work a case table: ACTH, cortisol, renin, aldosterone and K+ in Cushing disease, ectopic ACTH, adrenal adenoma, Addison disease and Conn syndrome.
21.6

Endocrine Pancreas and Other Endocrine Tissues

1.5 hFriday, Mar 5, Week 16

Outcomes

  1. 30Identify alpha, beta and delta cells in an islet and give the hormone and location (islet center or periphery) of each.
  2. 31Describe insulin synthesis from preproinsulin to proinsulin and C-peptide and the glucose-stimulated pathway of release.
  3. 32Explain insulin receptor signalling and the effects on liver, muscle and adipose tissue, including GLUT4 recruitment.
  4. 33Explain glucagon actions and the counter-regulatory response to hypoglycemia.
  5. 34Compare type 1 diabetes, type 2 diabetes and diabetic ketoacidosis in mechanism, laboratory findings and acute and chronic complications.
  6. 35Summarize the hormones of the pineal, gonads, placenta, gut, kidney, heart and adipose tissue and their stimuli.

Outline

  1. A

    Islet anatomy and histology

    1. About 1 million islets of Langerhans make 1-2 percent of the pancreas, more abundant in the tail spot-check; richly fenestrated capillaries.
    2. Alpha cells (about 20 percent, glucagon, periphery), beta cells (about 70 percent, insulin and amylin, core), delta cells (somatostatin), PP cells (pancreatic polypeptide) spot-check.
    3. On H&E islets appear as pale clusters among darker exocrine acini.
    4. Insulin is the standard example of protein synthesis and processing in R&P.
  2. B

    Insulin synthesis and secretion

    1. Preproinsulin yields proinsulin in the ER; Golgi cleaves it to insulin plus C-peptide in equimolar amounts; C-peptide measures endogenous secretion.
    2. Glucose enters beta cells via GLUT2, glucokinase sets the sensing rate, rising ATP closes K-ATP channels, depolarizes the membrane, opens voltage-gated Ca2+ channels, and Ca2+ triggers granule exocytosis.
    3. Sulfonylureas close K-ATP channels directly; GLP-1 and GIP (incretins) amplify glucose-dependent secretion via cAMP; amino acids, vagal ACh and beta-adrenergic stimulation promote, alpha-2 stimulation inhibits.
    4. Biphasic release: a rapid first phase from stored granules and a sustained second phase.
  3. C

    Insulin signalling and actions

    1. Receptor tyrosine kinase (alpha2-beta2) phosphorylates IRS, activating PI3K-Akt (metabolic) and Ras-MAPK (mitogenic) arms.
    2. Muscle and fat: GLUT4 translocation, glycogen synthesis, protein synthesis, lipogenesis, inhibition of hormone-sensitive lipase.
    3. Liver (insulin-independent GLUT2): increased glycogen synthesis and lipogenesis, suppression of gluconeogenesis and ketogenesis.
    4. Lowers K+ by stimulating Na+/K+-ATPase, used to treat hyperkalemia.
    5. Half-life about 5-6 minutes spot-check, cleared by liver and kidney.
  4. D

    Glucagon and counter-regulation

    1. Glucagon acts through Gs-cAMP-PKA in the liver: glycogenolysis, gluconeogenesis, ketogenesis, little effect on muscle.
    2. Release rises with hypoglycemia, amino acids and sympathetic input; insulin and somatostatin suppress it.
    3. Response to hypoglycemia in order: insulin falls, glucagon and epinephrine rise, then cortisol and GH over hours.
  5. E

    Diabetes mellitus

    1. Type 1: autoimmune beta-cell destruction (anti-GAD, islet-cell antibodies), absolute insulin deficiency, ketosis-prone.
    2. Type 2: insulin resistance with relative deficiency and beta-cell failure; strongly linked to obesity; ketoacidosis rare but hyperosmolar state occurs.
    3. Diabetic ketoacidosis: hyperglycemia, ketonemia, anion-gap acidosis, osmotic diuresis, K+ depletion despite normal or high serum K+.
    4. Diagnostic thresholds include fasting glucose 126 mg/dL or greater and HbA1c 6.5 percent or greater spot-check.
    5. Chronic complications result from glycation and polyol injury to small vessels: retinopathy, nephropathy, neuropathy, plus macrovascular disease.
  6. F

    Other endocrine tissues

    1. Pineal: melatonin from tryptophan via serotonin, released at night, entrained by retinohypothalamic input to the suprachiasmatic nucleus and sympathetic fibers; regulates sleep-wake timing.
    2. Gonads: testosterone and inhibin from Leydig and Sertoli cells; estrogen, progesterone and inhibin from the ovary (detail in later chapters).
    3. Placenta: hCG sustains the corpus luteum, with progesterone, estrogen and human placental lactogen later.
    4. GI: gastrin, secretin, CCK, GIP, GLP-1, ghrelin; kidney: erythropoietin, calcitriol, renin; heart: ANP and BNP; adipose: leptin and adiponectin; thymus: thymosin.

Lab

  • Histology Guide MH-131 and MH-133: find islets within exocrine acini and compare their staining and capillary density.
  • R&P plate 64 (pancreas) and plate 78 (pineal): identify islets, acini, and pineal brain sand.
  • Label pancreas head, neck, body, tail and relations on NET plate 288.
  • Graph insulin, glucagon, glucose and ketones over a 12-hour fast, and after a mixed meal.
  • Draw the beta-cell stimulus-secretion coupling cascade and mark where sulfonylureas, GLP-1 agonists and diazoxide act.

Teach-back prompts

  1. Pick one hormone each from the peptide, steroid and thyroid classes and explain how the class determines its storage, transport, receptor location and onset of action.
  2. Walk through the hypothalamic-pituitary-thyroid axis, then use TSH and free T4 to explain how you would tell primary hypothyroidism, central hypothyroidism and Graves disease apart.
  3. Describe how the body responds to a fall in plasma Ca2+ across PTH, vitamin D, bone, kidney and gut.
  4. Explain the zones of the adrenal cortex and how a 21-hydroxylase block produces the hormone pattern seen in congenital adrenal hyperplasia.
  5. Compare the beta-cell secretion pathway with the insulin signalling pathway, and explain why type 1 diabetes can lead to ketoacidosis while type 2 less commonly does.

Practical targets

  • Pituitary pars distalis versus pars nervosa (Histology Guide MH-149)
  • Acidophils, basophils and chromophobes (R&P plate 76)
  • Herring bodies (R&P plate 77)
  • Pineal brain sand (R&P plate 78)
  • Thyroid follicle with colloid (Histology Guide MH-151)
  • Parafollicular C cell (R&P plate 79)
  • Parathyroid chief and oxyphil cells (Histology Guide MH-154)
  • Adrenal zona glomerulosa, fasciculata and reticularis (Histology Guide MH-155a)
  • Adrenal medulla chromaffin cells (R&P plate 81)
  • Pancreatic islet (Histology Guide MH-131)
  • Thyroid gland, anterior view (NET plate 87)
  • Parathyroid glands, posterior view (NET plate 89)
  • Hypothalamus and hypophysis (NET plate 158)
  • Suprarenal arteries and veins (NET plate 323)
  • Pancreas in situ (NET plate 288)

Also see